1. Murphy WK, Huber M, Fossella FV, et al. Phase I study of taxol (T), cisplatin (P) and etoposide (E) with G-CSF (G) in patients (PTS) with non-small cell lung cancer (NSCLC). PASCO 1995, 14, 354 (#1076).
2. Levitan N, McKenney J, Tahsildar H, et al. Results of a phase I dose escalation trial of paclitaxel, etoposide and cisplatin followed by filgrastim in the treatment of patients with extensive stage small cell lung cancer. PASCO 1995, 14, 379 (#1177).
3. Paclitaxel in combination chemotherapy with radiotherapy in patients with unresectable stage III non small cell lung cancer;Greco;J Clin Oncol,1996
4. Lokich J, Anderson N, Bern M, et al. Multi-day fractionated administration schedule for paclitaxel. Ann Oncol 1995, 6(9), 883–886.